Yi'an Science and Technology: the company's foreign sales of magnesium bone nails are affected by the global epidemic later than expected.

Some investors asked on the investor interactive platform: how are the sales and profits of magnesium bone nails abroad? If sales in Europe and the United States are far below expectations and can't make money, will there be a domestic market? If so, is it necessary to carry out the third phase in China? Is it necessary to spend so much money on a product with no market and strong substitution?

300328.SZ said on the investor interactive platform on Oct. 19 that its overseas sales of magnesium bone nails were affected by the global epidemic and the progress was later than expected. Domestic clinical non-staging, according to the clinical plan, only 184 cases were enrolled in the group (92 cases in the experimental group and 92 cases in the control group). The company's high-purity magnesium biodegradable bone nail has many advantages, such as single element, no need to consider the toxic effect of multi-elements, good biocompatibility, mechanical properties close to bone tissue, no stress shielding effect, and can be removed from the second operation. The company is firmly optimistic about its application prospect.